Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-11-13

Clinical Trial Update: Intravenous Iron Isomaltoside Versus Oral Iron Supplementation for Treatment of Iron Deficiency in Pregnancy. [Phase 4]

View source ↗

Summary

Phase 4 trial comparing intravenous iron isomaltoside to oral iron for iron deficiency anemia in pregnancy has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • iron isomaltoside (intravenous) (iron isomaltoside)

Snippet

Sponsor: Pharmacosmos A/S | Conditions: Iron Deficiency Anemia of Pregnancy | Phase 4 | Status: COMPLETED